BCRX

BioCryst Pharmaceuticals Stock Price

3.5198
0.0848 (2.47%)
3.5198
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0848 2.47% 3.5198 08:40:17
Close Price Low Price High Price Open Price Previous Close
3.435
Bid Price Ask Price Spread News
3.48 3.52 0.04 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
151 366,728 $ 3.57 $ 1,308,371 5,578,961 1.38 - 6.43
Last Trade Time Type Quantity Stock Price Currency
08:40:17 formt 901 $ 3.5198 USD

BioCryst Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 619.75M 176.57M 164.27M $ 48.84M $ - -0.94 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 62.62k 2.50%

more financials information »

BioCryst Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.463.863.303.546,071,4620.05981.73%
1 Month3.854.203.303.735,380,887-0.3302-8.58%
3 Months5.585.823.304.256,026,464-2.06-36.92%
6 Months1.956.431.804.158,307,4481.5780.5%
1 Year2.876.431.383.686,050,5020.649822.64%
3 Years5.209.971.384.082,783,425-1.68-32.31%
5 Years11.4012.881.384.402,151,343-7.88-69.12%

BioCryst Pharmaceuticals Description

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.


Your Recent History
NASDAQ
BCRX
BioCryst P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.